Laura Zeller/LinkedIn and Menno Germans/LinkedIn
Dec 20, 2025, 07:41
Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies
RPTH Journal shared a post on LinkedIn:
“In emergency neurosurgery, rapid DOAC reversal is critical. This systematic review evaluates perioperative outcomes of idarucizumab and andexanet alfa, highlighting evidence gaps and safety insights.
If you work in hemostasis, neurosurgery, or acute care, this one’s worth a look.
Senior Author: Menno Germans”
Title: Specific reversal agents for direct oral anticoagulants in neurosurgical emergencies – a systematic review
Authors: Laura Zeller, Jonas Rohr, Giovanna Brandi, Christoph Globas, Alexander Kaserer, Matthias Greutmann, Tilman Schubert, Jan-Dirk Studt, Katharina Geiling, Luca Regli, Menno R. Germans
Never miss hematology news with Hemostasis Today.
-
Aug 22, 2026, 13:38Jerome Hadjadj: A New Approach to Refractory Immune Thrombocytopenia
-
Aug 22, 2026, 13:25Christopher Robinson: Hematologic Response to Iron Therapy and Stillbirth Risk
-
Aug 22, 2026, 13:24Philippa Hill: Blood Clot Awareness – Recognize the Signs, Prevent the Risk
-
Aug 22, 2026, 13:21Chokri Ben Lamine: ASH 2026 Adult Primary ITP Guidelines – Practice-Changing Update
-
Aug 22, 2026, 13:07Saneha Anjum Shaikh: Blood Bank Basics and Quality Control in Automation
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?